共 50 条
- [2] Sacituzumab Govitecan in Metastatic Breast Cancer REPLY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):
- [4] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1529 - 1541
- [5] Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial [J]. LANCET, 2024, 404 (10450): : 337 - 338